Astrocyte Pharmaceuticals secures over $6m for brain injury treatments

Astrocyte Pharmaceuticals Inc., a vanguard in the realm of cerebroprotective drug discovery, has amassed over $6 million in an oversubscribed pre-Series B Bridge financing round. ... Read More